GABAergic transmission and tyrosine hydroxylase expression in the nigral dopaminergic neurons: An in vivo study using a reversible ischemia model of rats

Neuroscience

Volumn 73, Issue 3, 1996, Pages 783-789

  Yamada, K ^a   Goto, S ^a   Yoshikawa, M ^a   Ushio, Y ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

glutamate decarboxylase; striatal ischemia; transient middle cerebral artery occlusion; transneuronal degeneration

Indexed keywords

DOPAMINE; MUSCIMOL; TYROSINE 3 MONOOXYGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; GABAERGIC TRANSMISSION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL DEGENERATION; NISSL SUBSTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TRANSIENT ISCHEMIC ATTACK;

EID: 0030219023     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00041-3     Document Type: Article

References (40)

1. 1. Alexander G. E., Crutches M. D. and DeLong M. R. (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. In The Prefrontal Cortex: Its Structure, Function and Pathology (eds Uylings H. B. M., Van Eden C. G., De Bruin J. P. C., Corner M. A. and Feenstra M. G. P.), pp.119-146. Progress in Brain Research, Vol. 85, Elsevier, Amsterdam.
2. 2. Bolam J. P. and Smith Y. (1990) The GABA and substance P input to dopaminergic neurons in the substantia nigra of rat. Brain Res. 529, 57-78.
3. 3. Brown A. W., Levy D. E., Kublik M., Harrow J., Plum F. and Brierley J. B. (1979) Selective chromatolysis of neurons in the gerbil brain: A possible consequence of "epileptic" activity produced by common carotid artery occlusion. Ann. Neurol. 5, 127-138.
4. 4. Carlsson A. and Lindqvist M. (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxy-tyramine and normetanephrine in mouse brain. Acta pharmac. (Kbh.) 20, 140-144.
5. 5. Chéramy A., Nieoullon A. and Glowinski J. (1978) GABAergic process involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat. Eur. J. Pharmac. 48, 281-295.
6. 6. Deniau J. M., Kitai S. T., Donoghue J. P. and Grofová I. (1982) Neuronal interaction in the substantia nigra pars reticulata through axon collaterals of the projection neurons. Expl Brain Res. 47, 105-113.
7. B-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra. Synapse 15, 229-238.
8. 8. Fisher R. S. (1989) GABA-ergic pallidonigral and 'accessory' striatonigral connections demonstrated in cats by double peroxidase labeling. Synapse 4, 154-167.
9. 9. Fisher R. S., Buchwald N. A., Hull C. D. and Levine M. S. (1986) The GABAergic striatonigral neurons of the cat: demonstration by double peroxidase labeling. Brain Res. 398, 148-156.
10. 10. Forno L. S. (1983) Reaction of the substantia nigra to massive basal ganglia infarction. Acta Neuropath., Berlin 62, 96-102.
11. 11. Freund T. F., Powell J. and Smith A. D. (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13, 1189-1215.
12. 2+ calmodulin-regulated protein phosphatase, calcineurin. Neuroscience 62, 695-705.
13. 13. Graybiel A. M. and Ragsdale C. W. (1983) Biochemical anatomy of the striatum. In Chemical Neuroanatomy (ed. Emson P. C.), pp.427-504. Raven, New York.
14. 14. Grofová I., Deniau J. M. and Kitai S. T. (1982) Morphology of the substantia nigra pars reticulata projection neurons intracellularly labeled with HRP. J. comp. Neurol. 208, 352-368.
15. 15. Isacson O., Brundin P., Gage F. H. and Björklund A. (1985) Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience 16, 799-817.
16. 16. Kaufman D. L., McGinnis J. F., Krieger N. R. and Tobin A. J. (1991) Two forms of the GABA synthetic enzyme glutamate decarboxylase have distinct interneuronal distribution. J. Neurochem. 56, 720-723.
17. 17. Krammer E. B. (1980) Anterograde and transsynaptic degeneration 'en cascade' in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington's disease. Brain Res. 196, 209-221.
18. 18. Leviel V., Chéramy A., Nieoullon A. and Glowinski J. (1979) Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and GABA related compounds. Brain Res. 175, 259-270.
19. 19. Nakane M., Teraoka A., Asato R. and Tamura A. (1992) Degeneration of the ipsilateral substantia nigra following cerebral infarction in the striatum. Stroke 23, 328-332.
20. 20. Nitsch C., Mews K., Wagner A. and Hassler R. (1984) Effects of frontal motor cortex ablation on the ultrastructure of cat substantia nigra. Acta anat. 119, 193-202.
21. 21. Nitsch C. and Riesenberg R. (1988) Immunocytochemical demonstration of GABAergic synaptic connections in the rat substantia nigra after different lesions of the striatonigral projection. Brain Res. 461, 127-142.
22. 22. Oertel W. H., Schmechel D. E., Brownstein M. J., Tappaz M. L., Ransom D. H. and Kopin I. J. (1981) Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of striatum. J. Histochem. Cytochem. 29, 977-980.
23. 23. Ohara S., Kondo K., Kagoshima M. and Yanagisawa N. (1989) Secondary degeneration of substantia nigra following massive basal ganglia infarction. Clin. Neurol., Tokyo 29, 1352-1356.
24. 24. Pasinetti G. M., Morgan D. G. and Finch C. E. (1991) Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: evidence for transneuronal regression. Expl Neurol. 112, 131-139.
25. 25. Reid M. S., Herrera-Marschitz M., Hökfelt T., Terenius L. and Understedt U. (1988) Differential modulation of striatal dopamine release by intranigral injection of γ-aminobutyric acid (GABA), dynorphin A and Substance P. Eur. J. Pharmac. 147, 411-420.
26. 26. Reid M. S., Herrera-Marschitz M. and Ungerstedt U. (1990) Effects of intranigral substance P and neurokinin A on striatal dopamine release. II. Interactions with bicuculline and naloxone. Neuroscience 36, 659-667.
27. 27. Reis D. J., Gilad G., Pickel V. M. and Joh T. H. (1978) Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods. Brain Res. 144, 325-342.
28. 28. Ribak C. E., Baughn J. E., Saito K., Barber R. and Roberts E. (1976) Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra. Brain Res. 116, 287-298.
29. 29. Roberts E. (1976) Disinhibition as an organizing principle in the nervous system - the role of the GABA system, application to neurologic and psychiatric disorders. In GABA in Nervous System Function (eds Roberts E., Chase T. N. and Tower D. B.), pp.515-539. Raven Press, New York.
30. 30. Saji M. and Reis D. J. (1987) Delayed transneuronal death of substantia nigra neurons prevented by γ-aminobutyric acid agonist. Science 235, 66-69.
31. 31. Santiago M. and Westerink B. H. (1992) The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats. Eur. J. Pharmac. 219, 175-181.
32. 32. Saper C. B. and Petito C. K. (1982) Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups. Brain 105, 87-101.
33. 33. Smith A. D. and Bolam J. P. (1990) The neuronal network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 13, 259-265.
34. 34. Smith Y. and Bolam J. P. (1990) The output neurones and the dopaminergic neurons of the substantia nigra receive a GABA-containing input from the globus pallidus in the cat. J. comp. Neurol. 296, 47-64.
35. 35. Somogyi P., Bolam J. P., Totterdell S. and Smith A. D. (1981) Monosynaptic input from the nucleus accumbens-ventral striatum region to retrogradely labelled nigrostriatal neurons. Brain Res. 217, 245-263.
36. 36. Tamura A., Kirino T., Sano K., Takagi K. and Oka H. (1990) Atrophy of the ipsilateral substantia nigra following middle cerebral artery occlusions in the rat. Brain Res. 510, 154-157.
37. 37. Wassef M., Berod A. and Sotelo C. (1981) Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration. Neuroscience 6, 2125-2139.
38. 38. Wasterlain C. G. (1972) Breakdown of brain polysomes in status epilepticus. Brain Res. 39, 278-284.
39. 39. Waszczak B. L., Eng N. and Walters J. R. (1980) Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons. Brain Res. 188, 185-197.
40. 40. Yamada K., Goto S. and Ushio Y. (1994) Occurrence of heat shock response in deafferented neurons in the substantia nigra of rats. Neuroscience 62, 793-801.